News und Analysen
![Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 208% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi: https://www.irw-press.at/prcom/images/messages/2023/71290/Aktiencheck110723_01.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDlKYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--787d8ebddd6748c6adbc693ec025f1daf5be4277/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck110723_01.001.png?locale=de)
Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 208% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi
Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Aktientip nach 134452%
11.07.23
London (www.aktiencheck.de, Anzeige)
![3 Stocks that Analysts Continue to Upgrade into Earnings Season: https://www.marketbeat.com/logos/articles/med_20230710103919_3-stocks-that-analysts-continue-to-upgrade-into-ea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0JJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6d48418cdefa572eb5dc3539f217fd530805a7a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230710103919_3-stocks-that-analysts-continue-to-upgrade-into-ea.jpg?locale=de)
3 Stocks that Analysts Continue to Upgrade into Earnings Season
One simple signal that investors can use to decide if a stock is likely to move higher is to look at analyst sentiment. An analyst is a market professional employed by either funds that buy
![Meta Threads Its Way To New Heights: https://www.marketbeat.com/logos/articles/med_20230710095453_chart-meta-7102023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0ZJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1b8ca42031d59bfd640f8a145cc37b6d0aa0b09/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230710095453_chart-meta-7102023.png?locale=de)
Meta Threads Its Way To New Heights
Meta (NASDAQ: META) took the tech world by storm again with its Threads announcement. Threads is a new app built by the Instagram team that allows functionality akin to Twitter. Users log in using
![The 3 Hot Sectors To Watch During The Summer Reporting Season: https://www.marketbeat.com/logos/articles/med_20230710080927_chart-xlc-7102023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFZJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ea9a956ef7360ad98ceac29e799d4e203e98ba89/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230710080927_chart-xlc-7102023.png?locale=de)
The 3 Hot Sectors To Watch During The Summer Reporting Season
Market participants may have positioned in May and gone away, but the analysts have remained active. They continue to update the earnings outlook, and the first few reports from S&P 500 (NYSEARCA:
![Can ChatGPT AI Revitalize Microsoft's Bing Search Engine?: https://www.marketbeat.com/logos/articles/med_20230709132206_chart-msft.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDFJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7f6b3b087d6270a8a0793d438d9441b8a76bb727/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230709132206_chart-msft.jpg?locale=de)
Can ChatGPT AI Revitalize Microsoft's Bing Search Engine?
Technology provider Microsoft Co. (NYSE: MSFT) has garnered much of the spotlight in mainstream artificial intelligence (AI) adoption in 2023. Open.ai’s launch of ChatGPT kicked off the AI mania
![Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi: https://www.marketbeat.com/logos/articles/med_20230707134150_biogen-shares-fall-after-fda-approval-of-alzheimer.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmRJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1dbde6a5e8e414c90db91c96080cd62ebf404107/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230707134150_biogen-shares-fall-after-fda-approval-of-alzheimer.jpg?locale=de)
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi
Stocks often react differently from the way you think they might. That happened on July 7 as shares of Biogen Inc. (NASDAQ: BIIB) swooned 2.88% in heavy trading volume following news of full
![Why Buying The Dip In Alphabet (Google) Could Yield Big Returns: https://www.marketbeat.com/logos/articles/med_20230710053121_why-buying-the-dip-in-google-could-yield-big-retur.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenhJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dfb14dd5703a7345a65c1906babab61f9f052cb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230710053121_why-buying-the-dip-in-google-could-yield-big-retur.jpg?locale=de)
Why Buying The Dip In Alphabet (Google) Could Yield Big Returns
Alphabet shares (NASDAQ: GOOGL) are finding support at a previous area of resistance, pointing toward a potential upside in the stock if buyers can continue to stand firm. On the year, shares of
![Hautkrebs bald besiegt? Round Table mit Europas Top-Forschern. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 210% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi: https://www.irw-press.at/prcom/images/messages/2023/71270/AC-100723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzlJYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a7bf8398bb6a9cb8511ab94d21b47a578fbf7566/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-100723.001.png?locale=de)
Hautkrebs bald besiegt? Round Table mit Europas Top-Forschern. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 210% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi
Hautkrebs bald besiegt? Round Table mit Europas Top-Forschern. 210% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
10.07.23 08:11
London (www.aktiencheck.de, Anzeige)
![Pfizer Just Invested $25 million In This Biotech: https://www.marketbeat.com/logos/articles/med_20230707085820_pfizer-just-invested-25-million-in-this-biotech.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGxIYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--262be44f890d0485b2cae73bedbf5cf6c7ecbcc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230707085820_pfizer-just-invested-25-million-in-this-biotech.jpg?locale=de)
Pfizer Just Invested $25 million In This Biotech
Shares of Caribou Biosciences (NASDAQ: CRBU) were up 45% yesterday after Pfizer (NYSE: PFE) made a $25 million equity investment. On Thursday, the company said Pfizer bought almost 4.7 million
![Cracks In The Labor Market? Not Yet, But They’re Coming: https://www.marketbeat.com/logos/articles/med_20230707083635_chart-spy-772023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHBIYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e05c51e2a15b54de8e0229d7f3eb55610aa88131/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230707083635_chart-spy-772023.png?locale=de)
Cracks In The Labor Market? Not Yet, But They’re Coming
The June employment situation summary revealed weaker-than-expected job growth and a potential crack in the labor market. The news suggests weakening demand for employment and is backed up by
![Who Wins And Who Loses With China's Metal Restrictions: https://www.marketbeat.com/logos/articles/med_20230707073456_who-wins-and-who-loses-with-chinas-metal-restricti.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHhIYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--79e8c382b3975073d0c083dac0251eb66d0ada75/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230707073456_who-wins-and-who-loses-with-chinas-metal-restricti.jpg?locale=de)
Who Wins And Who Loses With China's Metal Restrictions
It is no secret that the trade wars between the United States and China have only intensified over the past several months, with escalations being explicitly made on the chip and semiconductor
![Three AI Trades That Could Double This Year: https://www.marketbeat.com/logos/articles/med_20230706125832_chart-peri-762023-002.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2xIYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--141e2112d285d9b250dd892c391e9c03ae885ad0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706125832_chart-peri-762023-002.png?locale=de)
Three AI Trades That Could Double This Year
AI and, specifically, generative AI are the hottest topics this year. While big-name players like NVIDIA (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and Microsoft (NASDAQ: MSFT) will
![2 Airlines Whose PE Ratios Scream Good Value: https://www.marketbeat.com/logos/articles/med_20230706083614_2-airlines-whose-pe-ratios-scream-good-value.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK2RHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ac80ee927436480ccc7119f10aa1433451c045c8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706083614_2-airlines-whose-pe-ratios-scream-good-value.jpg?locale=de)
2 Airlines Whose PE Ratios Scream Good Value
We wrote about Amazon Inc (NASDAQ: AMZN) yesterday and how its elevated price-to-earnings (PE) ratio is likely giving investors cause for concern, notwithstanding its recent rally. While it may be
![Perion Network Is Monetizing The Internet And Delivering Value: https://www.marketbeat.com/logos/articles/med_20230706111631_chart-peri-762023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1ZHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--84cb6b24e2cf1b036540a2066359dc118ddd5d23/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706111631_chart-peri-762023.png?locale=de)
Perion Network Is Monetizing The Internet And Delivering Value
Perion Network (NASDAQ: PERI) is emerging as a stand-alone play on digitization and a potential takeover target for more prominent players. It’s Wildfire platform and a suite of applications
![Hautkrebs bald besiegt? Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 212% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 212% mit Biotech Ak: https://www.irw-press.at/prcom/images/messages/2023/71257/AC-070723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHBHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0d3a54f1f977c1100e4201991eea788b0e347107/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-070723.001.png?locale=de)
Hautkrebs bald besiegt? Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 212% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 212% mit Biotech Ak
Hautkrebs bald besiegt? Erstkl. Studienergebnisse. Massives Kaufsignal. 212% Biotech Hot Stock nach 134.452% mit Biogen
07.07.23 08:02
London (www.aktiencheck.de, Anzeige)
![Could Meta Be Risking Another Sell Off With Its New "Threads"?: https://www.marketbeat.com/logos/articles/med_20230706072956_could-meta-be-risking-another-sell-off-with-its-ne.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEpGYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--33c1ce02d98ab93209a7ffeaf7428eb54cb170da/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706072956_could-meta-be-risking-another-sell-off-with-its-ne.jpg?locale=de)
Could Meta Be Risking Another Sell Off With Its New "Threads"?
Mark Zuckerberg has started a battle on more than one front. He has chosen not only the company that has most effectively dominated short-form written content but also an adversary known to be a
![2 Must-Have Specialized ETFs for the Long-Term Investor: https://www.marketbeat.com/logos/articles/med_20230706072614_2-must-have-specialized-etfs-for-the-long-term-inv.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEJGYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--24e7decf40cfa084143b02d4247c7f89ce160fcd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706072614_2-must-have-specialized-etfs-for-the-long-term-inv.jpg?locale=de)
2 Must-Have Specialized ETFs for the Long-Term Investor
Constructing a long-term investment portfolio can be a lot like building a house.
First, you pour in the foundation. These are the tried and true pillars that have been around for decades — and
![Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy: https://www.marketbeat.com/logos/articles/med_20230706072115_inspire-medical-up-15-after-breakout-analysts-say.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEZGYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d93c1e48be6f980dcbdddeaf24104c58d261befa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230706072115_inspire-medical-up-15-after-breakout-analysts-say.jpg?locale=de)
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
Inspire Medical Systems (NYSE: INSP) is up nearly 15% since breaking out of cup-with-handle base on May 3. The base’s buy point was above $277.18, which you can see on the Inspire Medical Systems
![Yield Curve Tests New Lows, Where Markets Are Seeking Safety: https://www.marketbeat.com/logos/articles/med_20230705105219_yield-curve-tests-new-lows-where-markets-are-seeki.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2xGYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a3044edd3f586b1349ce814c96112df534d46174/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705105219_yield-curve-tests-new-lows-where-markets-are-seeki.jpg?locale=de)
Yield Curve Tests New Lows, Where Markets Are Seeking Safety
As markets come to a significant turning point, investors can benefit from understanding where money has been and where it may be going into, as pivots in the flow of investment preferences
![Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vida: https://www.irw-press.at/prcom/images/messages/2023/71245/AC-060723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeE5GYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--56515343a35b8591b959e4c64524c8811c3d4a26/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-060723.001.png?locale=de)
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vida
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 15.973% mit BioNTech
06.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![3 Russell 2000 Stocks to Buy as Small-Caps Make a Comeback: https://www.marketbeat.com/logos/articles/med_20230705102931_3-russell-2000-stocks-to-buy-as-small-caps-make-a.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTFFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--30b2283d949796e1e18897d7c2d7a6e10cac9e7c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705102931_3-russell-2000-stocks-to-buy-as-small-caps-make-a.jpg?locale=de)
3 Russell 2000 Stocks to Buy as Small-Caps Make a Comeback
The Russell 2000 Index (INDEXRUSSELL: RUT) is a market index made up of 2,000 small-cap companies. The companies in the index make up the bottom two-thirds of company size in the Russell 3000
![These Banks Are Boosting Dividends After Safe Stress Tests: https://www.marketbeat.com/logos/articles/med_20230705101401_these-banks-are-boosting-dividends-after-safe-stre.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--227ef49e1b6dcf0b0f32e35031840a4dbca1e266/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705101401_these-banks-are-boosting-dividends-after-safe-stre.jpg?locale=de)
These Banks Are Boosting Dividends After Safe Stress Tests
After the collapse of Silicon Valley Bank (NASDAQ: SIVB) a few months ago, regional and larger banks across the United States saw their stocks decline as a systematic reaction to the news. As is a
![3 Cash-Rich Defensive Companies Making Investors Rich: https://www.marketbeat.com/logos/articles/med_20230705090053_3-cash-rich-defensive-companies-making-investors-r.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNUpFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--40860026f10381e9c030c94e79593d4a8f3e393c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705090053_3-cash-rich-defensive-companies-making-investors-r.jpg?locale=de)
3 Cash-Rich Defensive Companies Making Investors Rich
The phrase “cash is king” can mean several different things depending on perspective.
To a local restaurant that only accepts cash payments, ‘cash is king.’ To investors in an overheated stock
![Amazon Is Having Its Best Run In Years, But Should You Chase It?: https://www.marketbeat.com/logos/articles/med_20230705084627_amazon-is-having-its-best-run-in-years-but-should.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2xFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6620dd504d7f15e65a92ee4f8c2a1b032b37e7a9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705084627_amazon-is-having-its-best-run-in-years-but-should.jpg?locale=de)
Amazon Is Having Its Best Run In Years, But Should You Chase It?
With fellow tech heavyweights like Apple Inc (NASDAQ: AAPL), Meta Inc (NASDAQ: META), and Alphabet Inc (NASDAQ: GOOGL) all seeing strong rallies this year, it should be no surprise that Amazon Inc
![Is The XLE Primed For A Potential Breakout?: https://www.marketbeat.com/logos/articles/med_20230705074040_is-the-xle-primed-for-a-potential-breakout.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHRFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--708ece7781d28d73792fa09fb4cf390ea7a1f09c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705074040_is-the-xle-primed-for-a-potential-breakout.jpg?locale=de)
Is The XLE Primed For A Potential Breakout?
The Energy Select Sector SPDR Fund (NYSE: XLE) is setting up on a higher time frame for a potential breakout. YTD, the sector ETF is down almost 7%. However, as the uptrend remains intact and the